3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
5
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Neoplasms
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Flow Cytometry
5
Polymerase Chain Reaction
4
Blood Specimen Collection
4
Therapeutics
3
Psychiatric Rehabilitation
3
Immunoenzyme Techniques
3
mogamulizumab
2
Biopsy
2
Amplified Fragment Length Polymorphism Analysis
2
Watchful Waiting
1
Valganciclovir
1
Urine Specimen Collection
1
Peripheral Blood Stem Cell Transplantation
1
Microarray Analysis
1
Influenza Vaccines
1
Indium
1
Immunosuppression Therapy
1
Immunohistochemistry
1
Hematologic Tests
1
Gene Rearrangement
1
Gene Expression Profiling
1
Ganciclovir
1
Foscarnet
1
Fluconazole
1
Fentanyl
1
Drug Therapy
1
Data Collection
1
Dapsone
1
Antiviral Agents
1
Amines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Mycosis Fungoides
×
Amines
×
Clear all
NCT02296164
2020-03-04
PROVe
Helsinn Therapeutics (U.S.), Inc
Completed
300 enrolled
7 charts